[HTML][HTML] Novel strategies to improve efficacy of treatment with tumor-infiltrating lymphocytes (TILs) for patients with solid cancers

L Tas, I Jedema, JBAG Haanen - Current Opinion in Oncology, 2023 - journals.lww.com
Novel strategies to improve efficacy of treatment with tumor... : Current Opinion in Oncology
Novel strategies to improve efficacy of treatment with tumor-infiltrating lymphocytes (TILs) for …

TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis

ILA Bodewes, E Huijser… - Journal of …, 2018 - Elsevier
Objective Upregulation of type I interferons (IFN-I) is a hallmark of systemic autoimmune
diseases like primary Sjögren's syndrome (pSS), systemic lupus erythematosus (SLE) and …

[HTML][HTML] Primary vulvar squamous cell carcinomas with high T cell infiltration and active immune signaling are potential candidates for neoadjuvant PD-1/PD-L1 …

KE Kortekaas, SJ Santegoets, L Tas… - … for Immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Background A profound insight into the immune landscape of vulvar squamous cell
carcinoma (VSCC) is lacking. Here, an in-depth interrogation of T cell infiltration, local …

[HTML][HTML] Management of infliximab refractory immune checkpoint inhibitor gastrointestinal toxicity: a multicenter case series

C Harvey, KJ Nahar, J McKeown, SN Lo… - … for Immunotherapy of …, 2024 - ncbi.nlm.nih.gov
Background Immune checkpoint inhibitor (ICI) gastrointestinal toxicity (gastritis, enteritis,
colitis) is a major cause of morbidity and treatment-related death. Guidelines agree steroid …

Management of infliximab-refractory immune checkpoint inhibitor gastrointestinal toxicity: A multicenter case series.

C Harvey, KJ Nahar, SN Lo, T Ahmed, S Farag… - 2022 - ascopubs.org
2665 Background: Immune checkpoint inhibitor (ICI) GI tox (gastritis, enteritis, colitis) is a
major cause of morbidity and treatment-related death. Guidelines agree steroid-refractory …

[PDF][PDF] Fatigue in Sjögren's syndrome: a search for

LG Leon, AJM Wijkhuijs… - Iris Louise Agaath …, 2019 - repub.eur.nl
ABSTRACT Background Primary Sjögren's syndrome (pSS) is a systemic autoimmune
disease, where patients often suffer from fatigue. Biological pathways underlying fatigue are …

Fatigue in Sjogren's Syndrome

I Bodewes, P van der Spek, L Leon, A Wijkhuijs… - Frontiers in …, 2019 - repub.eur.nl
Background: Primary Sjögren's syndrome (pSS) is a systemic autoimmune disease, where
patients often suffer from fatigue. Biological pathways underlying fatigue are unknown. In …

[CITATION][C] TBK1 inhibition downregulates expression of interferon type I and the upregulated expression of RIG-like receptors and DNA-sensing receptors in …

ILA Bodewes, E Huijser… - CLINICAL …, 2018 - … VIA SANTA MARIA 31, 56126 PISA …

[CITATION][C] Fatigue in Sjogren's syndrome: a search for biomarkers and treatment targets

I Bodewes, L Tas, A Wijkhuijs… - CLINICAL …, 2018 - … VIA SANTA MARIA 31, 56126 PISA …